Man Group’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$375K Buy
+45,200
New +$468K ﹤0.01% 2154
2025
Q4
Sell
-30,376
Closed -$268K 2309
2025
Q3
$268K Sell
30,376
-12,232
-29% -$95.1K ﹤0.01% 2038
2025
Q2
$272K Sell
42,608
-56,606
-57% -$324K ﹤0.01% 1983
2025
Q1
$482K Sell
99,214
-77,566
-44% -$642K ﹤0.01% 1809
2024
Q4
$1.69M Buy
+176,780
New +$1.62M 0.01% 1368
2024
Q1
Sell
-123,836
Closed -$297K 2154
2023
Q4
$297K Buy
+123,836
New +$291K ﹤0.01% 1820
2023
Q3
Sell
-449,955
Closed -$2.49M 1520
2023
Q2
$3.31M Buy
+449,955
New +$4.17M 0.01% 1033
2023
Q1
Sell
-879,448
Closed -$10.6M 696
2022
Q4
$10.4M Buy
879,448
+224,729
+34% +$3.48M 0.04% 551
2022
Q3
$13.7M Buy
+654,719
New +$18.2M 0.06% 373
2022
Q2
Sell
-22,070
Closed -$753K 416
2022
Q1
$906K Buy
+22,070
New +$973K ﹤0.01% 1405
2021
Q4
Sell
-15,000
Closed -$751K 1995
2021
Q3
$751K Buy
15,000
+6,400
+74% +$388K ﹤0.01% 1434
2021
Q2
$542K Buy
8,600
+4,323
+101% +$278K ﹤0.01% 1538
2021
Q1
$397K Sell
4,277
-40,817
-91% -$4.18M ﹤0.01% 1553
2020
Q4
$4.04M Sell
45,094
-125,198
-74% -$11.5M 0.02% 920
2020
Q3
$17.6M Buy
170,292
+84,979
+100% +$9.16M 0.07% 303
2020
Q2
$6.75M Buy
85,313
+58,348
+216% +$4.35M 0.03% 532
2020
Q1
$1.56M Buy
+26,965
New +$1.55M 0.01% 980
2019
Q4
Sell
-20,388
Closed -$1.06M 1844
2019
Q3
$1.06M Sell
20,388
-71,090
-78% -$3.31M ﹤0.01% 1418
2019
Q2
$4.42M Sell
91,478
-365,819
-80% -$17.5M 0.02% 1006
2019
Q1
$23.1M Sell
457,297
-112,305
-20% -$6.62M 0.09% 277
2018
Q4
$33.8M Sell
569,602
-11,177
-2% -$721K 0.15% 143
2018
Q3
$38.2M Sell
580,779
-253,886
-30% -$14.8M 0.14% 136
2018
Q2
$42.1M Buy
834,665
+7,217
+0.9% +$376K 0.18% 110
2018
Q1
$43.6M Buy
+827,448
New +$41.2M 0.2% 87

Other funds holding EBS